Paper12445288
GM-CSF-based cancer vaccines.
Dranoff G. Immunol Rev, 2002. Cited by 258 papers, by iCite.
Cite this record
ConductScience Library. GM-CSF-based cancer vaccines. Papers, record 12445288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12445288
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cancer Vaccines | Major topic |
| Granulocyte-Macrophage Colony-Stimulating Factor | Major topic |
| Neoplasms | Major topic |
| Adjuvants, Immunologic | |
| Animals | |
| Antigen Presentation | |
| Antigen-Presenting Cells | |
| Antigens, Neoplasm | |
| Antigens, Surface | |
| Clinical Trials, Phase I as Topic | |
| Humans | |
| Killer Cells, Natural | |
| Melanoma | |
| Mice | |
| Neoplastic Stem Cells | |
| T-Lymphocyte Subsets | |
| Tumor Cells, Cultured | |
| Vaccination |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA39542 | NCI NIH HHS | United States | P01CA039542 | PubMed and NIH | NIH RePORTER |
| CA74886 | NCI NIH HHS | United States | R01CA074886 | PubMed and NIH | NIH RePORTER |
Cited by146
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 258 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42891082 | Immunocytokines in cancer: a safety perspective. | Front Immunol | 2026 | https://conductscience.org/library/papers/42891082 | PubMed |
| 42699170 | Endolysosomal routing combined with immune stimulation enhances anti-tumor efficacy of an HPV16 mRNA therapeutic vaccine. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42699170 | PubMed |
| 42506636 | Therapeutic Cancer Vaccines: Mechanisms, Clinical Progress, and Future Directions. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42506636 | PubMed |
| 42188765 | Needle-Free Injection Enhances the Immunogenicity and Antitumor Efficacy of Whole-Cell Tumor Vaccines. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188765 | PubMed |
| 42170292 | Understanding the dual role of granulocyte-macrophage colony-stimulating factor in the lung cancer tumor microenvironment and its therapeutic implications. | Transl Lung Cancer Res | 2026 | https://conductscience.org/library/papers/42170292 | PubMed |
| 41475842 | Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/41475842 | PubMed |
| 41299103 | Natural products as therapeutic interventions for inflammation-mediated cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41299103 | PubMed |
| 40920775 | Targeting the Exon2 splice cis-element in PD-1 and its effects on lymphocyte function. | PLoS One | 2025 | https://conductscience.org/library/papers/40920775 | PubMed |
| 40887652 | Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy: results of SAKK 11/16, a phase IIa trial. | Exp Hematol Oncol | 2025 | https://conductscience.org/library/papers/40887652 | PubMed |
| 40878391 | Engineering Bacteria as Living Therapeutics in Cancer Therapy. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40878391 | PubMed |
| 40437549 | Immunoprevention of non-viral cancers: challenges and strategies for early intervention. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40437549 | PubMed |
| 40274339 | Anti-GM-CSF autoantibodies in myeloid leukemias. | Best Pract Res Clin Haematol | 2025 | https://conductscience.org/library/papers/40274339 | PubMed |
| 39335671 | Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy. | Biomedicines | 2024 | https://conductscience.org/library/papers/39335671 | PubMed |
| 39041242 | A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. | Cancer Res Commun | 2024 | https://conductscience.org/library/papers/39041242 | PubMed |
| 38933006 | Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens. | Fundam Res | 2023 | https://conductscience.org/library/papers/38933006 | PubMed |
| 38656354 | A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases. | Med Oncol | 2024 | https://conductscience.org/library/papers/38656354 | PubMed |
| 38302823 | Extracellular Matrix Scaffold-Assisted Tumor Vaccines Induce Tumor Regression and Long-Term Immune Memory. | Adv Mater | 2024 | https://conductscience.org/library/papers/38302823 | PubMed |
| 38043066 | Current status of vaccine immunotherapy for gastrointestinal cancers. | Surg Today | 2024 | https://conductscience.org/library/papers/38043066 | PubMed |
| 37539029 | Engineering a versatile and retrievable cell macroencapsulation device for the delivery of therapeutic proteins. | iScience | 2023 | https://conductscience.org/library/papers/37539029 | PubMed |
| 37262321 | Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade. | Cancer Immunol Res | 2023 | https://conductscience.org/library/papers/37262321 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD1D | 912 | PubTator's text mining | https://conductscience.org/library/genes/912 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12445288
GET https://conductscience.org/api/papers/v1/12445288/cited_by?page=2